Suppr超能文献

肝细胞癌中的雌激素受体

Estrogen receptors in hepatocellular carcinoma.

作者信息

Nagasue N, Ito A, Yukaya H, Ogawa Y

出版信息

Cancer. 1986 Jan 1;57(1):87-91. doi: 10.1002/1097-0142(19860101)57:1<87::aid-cncr2820570118>3.0.co;2-k.

Abstract

Estrogen receptors (ER) were assayed on hepatocellular carcinoma (HCC) and surrounding liver tissue in 30 adult patients. All specimens were obtained at the time of surgery. Cirrhosis of the liver was associated with 28 patients and chronic hepatitis in 2 patients. ERs were detected in 12 of 30 HCCs. The value ranged from 1.4 to 9.2 fmol/mg cytosol protein with the dissociation constant (Kd) value less than 1 nanomol. On the other hand, 13 of 28 cirrhotic livers had measurable amounts of the receptors that ranged from 1.5 to 4.1 fmol/mg cytosol protein. Two livers with chronic hepatitis did not have detectable amounts of ERs. The receptors were not detected in both the tumor and liver in ten patients. The ER titers in HCC did not have any correlation with serum levels of alpha-fetoprotein or carcinoembryonic antigen, hepatitis B virus profiles, and histologic types of the tumor. In the light of the current results, it would be of great interest whether hormone therapy can be used or not as a treatment of naturally occurring HCC in humans.

摘要

对30例成年患者的肝细胞癌(HCC)及周围肝组织进行了雌激素受体(ER)检测。所有标本均在手术时获取。28例患者伴有肝硬化,2例患者伴有慢性肝炎。30例HCC中有12例检测到ER。其值在1.4至9.2 fmol/mg胞浆蛋白之间,解离常数(Kd)值小于1纳摩尔。另一方面,28例肝硬化肝脏中有13例可检测到一定量的受体,其范围为1.5至4.1 fmol/mg胞浆蛋白。2例慢性肝炎患者的肝脏未检测到可检测量的ER。10例患者的肿瘤和肝脏中均未检测到受体。HCC中的ER滴度与血清甲胎蛋白或癌胚抗原水平、乙肝病毒谱及肿瘤组织学类型均无相关性。根据目前的结果,激素疗法是否可用于治疗人类自然发生的HCC将是一个非常有趣的问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验